Pharma Mar (OTCMKTS:PHMMF) Hits New 12-Month High – Here’s Why

Pharma Mar, S.A. (OTCMKTS:PHMMF)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares changing hands. The stock had previously closed at $75.00.

Analyst Upgrades and Downgrades

Separately, Chardan Capital upgraded shares of Pharma Mar to a “strong-buy” rating in a report on Thursday, August 1st.

Pharma Mar Price Performance

The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. The stock’s 50 day moving average is $66.55 and its 200-day moving average is $46.00.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.